Wang M, Zhou Z G, Du K P, Li S, Li Y D, Gao F, Gao M Y, Gao J B
Department of Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052,China.
Zhonghua Yi Xue Za Zhi. 2023 Feb 7;103(5):364-369. doi: 10.3760/cma.j.cn112137-20220727-01639.
To compare the safety and diagnostic efficiency of CT-guided trans-organ and non-trans-organ large needle biopsy in the diagnosis of pancreatic space-occupying lesions. The clinical data of 367 patients with pancreatic mass who underwent CT-guided percutaneous biopsy in the First Affiliated Hospital of Zhengzhou University from January 2019 to January 2022 were retrospectively analyzed, including 211 males and 156 females, aged 18 to 87 (60.7±11.8) years old. They were divided into a trans-organ route group (=142) and a non-trans-organ route group (=225) according to whether traversing the organs during the procedures. The imaging data, pathological results, puncture process and complications of patients of the two groups were recorded. The successful rate for obtaining tissue,one-time successful diagnosis rate, accuracy, sensitivity, specificity, false negative rate and the incidence of complications were compared between the two groups. There was no significant difference in baseline data between the two groups (all >0.05).There were 28, 57, 24, and 33 biopsies were performed via a pathway traversing liver, stomach, small bowel and colon, respectively. The overall sampling success rates of the two groups were 100%.The one-time successful diagnosis rate did not show statistically difference between the two groups [86.6%(123/142) vs 87.1%(196/225),=0.892]. There was no statistically difference in accuracy, sensitivity and false negative rates between trans-organ route group and non-trans-organ routegroup [92.3%(131/142) vs 92.0%(207/225), 91.8% (123/134) vs 90.0%(190/211) and 8.2% (11/134) vs 10.0%(21/211), all >0.05]. The specificity was 100% in both groups. The common complications of the two groups were increased pancreatic amylase and hematoma, and there was no significant difference in the incidence of complications between the trans-organ route group and the non-trans-organ route group [10.6% (15/142) vs 12.4% (28/225), =0.585]. In the trans-organ route group, 5 patients had increased pancreatic amylase and 10 patients had local hematoma, all of which were improved after conservative treatment. In the non-organ route group, 11 patients had elevated pancreatic amylase, and 17 patients had local hematoma, 1 case received surgical treatment due to bleeding, the rest were improved by conservative treatment. CT-guided percutaneous transabdominal organ large needle biopsy of pancreatic space-occupying lesions has the comparable diagnostic efficiency and safety as non-transabdominal organ approach.
比较CT引导下经器官与非经器官大针穿刺活检在胰腺占位性病变诊断中的安全性及诊断效率。回顾性分析2019年1月至2022年1月在郑州大学第一附属医院接受CT引导下经皮穿刺活检的367例胰腺肿块患者的临床资料,其中男性211例,女性156例,年龄18~87岁(60.7±11.8岁)。根据穿刺过程中是否经过器官将其分为经器官途径组(n = 142)和非经器官途径组(n = 225)。记录两组患者的影像资料、病理结果、穿刺过程及并发症情况。比较两组获取组织成功率、一次性成功诊断率、准确率、灵敏度、特异度、假阴性率及并发症发生率。两组基线资料比较差异无统计学意义(均P>0.05)。分别有28例、57例、24例和33例活检经肝、胃、小肠和结肠途径进行。两组总体取材成功率均为100%。两组一次性成功诊断率比较差异无统计学意义[86.6%(123/142)比87.1%(196/225),P = 0.892]。经器官途径组与非经器官途径组在准确率、灵敏度及假阴性率方面比较差异无统计学意义[92.3%(131/142)比92.0%(207/225),91.8%(123/134)比90.0%(190/211),8.2%(11/134)比10.0%(21/211),均P>0.05]。两组特异度均为100%。两组常见并发症为血淀粉酶升高及血肿,经器官途径组与非经器官途径组并发症发生率比较差异无统计学意义[10.6%(15/142)比12.4%(28/225),P = 0.585]。经器官途径组5例血淀粉酶升高,10例局部血肿,经保守治疗后均好转。非经器官途径组11例血淀粉酶升高,17例局部血肿,1例因出血行手术治疗,其余经保守治疗好转。CT引导下经皮经腹器官大针穿刺活检胰腺占位性病变与非经腹器官途径具有相当的诊断效率及安全性。